A) Inhibiting protein synthesis B) Reducing cellular metabolism C) Promoting apoptosis D) Promoting survival and growth
A) Ras B) Grb2 C) PIP3 D) PTEN
A) Serine/threonine kinase B) Histidine kinase C) Lipid kinase D) Tyrosine kinase
A) GAB B) PTEN C) IRS D) Sos1
A) Regulatory p85 and catalytic p110 subunits B) Two identical catalytic subunits C) Single catalytic subunit only D) Regulatory p110 and catalytic p85 subunits
A) Via its G protein-binding domain B) Via its kinase domain C) Via its lipid-binding domain D) Via its SH2 domain
A) PTEN B) Sos1 C) Ras D) Grb2
A) Akt B) Ras-GTP C) PIP3 D) PTEN
A) Cancer and type 2 diabetes B) Hypertension and arthritis C) Cystic fibrosis and asthma D) Anemia and malaria
A) 1000 B) 100 C) 10 D) 500
A) Via recruitment of PTEN B) Via inhibition of Grb2 C) Via direct phosphorylation of p85 D) Via G-protein beta-gamma dimers or Ras
A) Binding of an extracellular ligand B) Binding of intracellular PIP3 C) Loss of PTEN function D) Dephosphorylation of p85
A) Receptor degradation B) Receptor dimerization C) Nuclear translocation D) Lipid cleavage
A) Mitochondrial matrix B) Endoplasmic reticulum C) Plasma membrane D) Nuclear envelope
A) PI3K B) Akt C) PDK1 D) mTORC2
A) PI(3)P B) PI(3,4)P2 C) PI D) PI(3,4,5)P3
A) Plasma membrane B) Nucleus C) Cytosol D) Endoplasmic reticulum
A) Ser308 B) Thr473 C) Ser473 D) Thr308
A) mTORC2 B) DNA-PK C) ILK D) PDK1
A) Translocation to the nucleus B) Binding to inhibitory proteins C) Dephosphorylation by phosphatases D) Degradation by proteasomes
A) They increase B) They convert to PI C) They remain stable D) They decrease
A) CAMKK B) ILK C) mTORC2 D) PDK1
A) DNA damage B) PI3K activity C) Calcium depletion D) Heat shock
A) PTEN B) PP2A C) SHIP D) PHLPP
A) NEDD4-1 B) IRS-1 C) FoxO D) S6K1
A) PTEN B) PP2A C) SHIP D) PHLPP
A) CTMP B) SHIP C) PP2A D) PHLPP
A) It promotes the stability of PTEN mRNA B) It up-regulates the E3 ligase NEDD4-1 C) It activates the transcription of PTEN D) It directly phosphorylates PTEN to increase its activity
A) PTEN B) Akt C) PP2A D) mTORC1 |